NCT00170872View on ClinicalTrials.gov

6 Week Open-label Trial With Lumiracoxib 200mg o.d. in Primary Knee Osteoarthritis or Rheumatoid Arthritis

PHASE3CompletedINTERVENTIONAL

Enrollment

135

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

July 31, 2005

Conditions

OsteoarthritisRheumatoid Arthritis

Interventions

DRUG

Lumiracoxib

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY